Insider Transactions in Q2 2022 at Oncocyte Corp (OCX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Cavan M. Redmond Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.64%
|
-
|
|
Jun 24
2022
|
Andrew J. Last Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.93%
|
-
|
|
Jun 24
2022
|
Alfred D Kingsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.47%
|
-
|
|
Jun 24
2022
|
Melinda Griffith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Jun 24
2022
|
Jennifer L. Carter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Jun 24
2022
|
Andrew Arno Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.57%
|
-
|
|
Jun 24
2022
|
Pura Vida Investments, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
99,386
-0.31%
|
$99,386
$1.04 P/Share
|
|
May 18
2022
|
Li Yu VP Cntrllr/Prncpl Acctng Offcr |
SELL
Open market or private sale
|
Direct |
8,128
-32.51%
|
$8,128
$1.14 P/Share
|
|
May 18
2022
|
Li Yu VP Cntrllr/Prncpl Acctng Offcr |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Apr 14
2022
|
Pura Vida Investments, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,931,707
+17.44%
|
$5,931,707
$1.29 P/Share
|
|
Apr 14
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Apr 14
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,003,752
+20.45%
|
$6,003,752
$1.33 P/Share
|